Summit Financial LLC Boosts Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Summit Financial LLC raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 28.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 8,427 shares of the medical equipment provider's stock after purchasing an additional 1,865 shares during the quarter. Summit Financial LLC's holdings in Intuitive Surgical were worth $4,398,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Bennett Selby Investments LP grew its stake in shares of Intuitive Surgical by 3.9% in the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider's stock valued at $234,000 after buying an additional 17 shares during the period. Onefund LLC grew its position in Intuitive Surgical by 1.9% in the fourth quarter. Onefund LLC now owns 947 shares of the medical equipment provider's stock worth $494,000 after acquiring an additional 18 shares during the period. LVW Advisors LLC lifted its position in Intuitive Surgical by 1.3% in the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider's stock valued at $756,000 after buying an additional 19 shares during the last quarter. Wesbanco Bank Inc. raised its stake in shares of Intuitive Surgical by 1.6% in the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider's stock valued at $635,000 after acquiring an additional 19 shares during the period. Finally, Journey Strategic Wealth LLC lifted its stake in Intuitive Surgical by 1.9% during the fourth quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider's stock worth $542,000 after purchasing an additional 19 shares in the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG traded down $42.22 during trading on Friday, reaching $452.39. The company had a trading volume of 2,912,936 shares, compared to its average volume of 1,539,117. The stock's fifty day moving average price is $547.83 and its 200 day moving average price is $532.58. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The firm has a market capitalization of $161.13 billion, a price-to-earnings ratio of 70.59, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55.

Insider Activity at Intuitive Surgical

In related news, EVP Myriam Curet sold 408 shares of the company's stock in a transaction that occurred on Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total value of $240,618.00. Following the sale, the executive vice president now owns 353 shares in the company, valued at $208,181.75. This represents a 53.61 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CFO Jamie Samath sold 94 shares of the company's stock in a transaction on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the sale, the chief financial officer now directly owns 2,630 shares in the company, valued at $1,502,019.30. This trade represents a 3.45 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 33,754 shares of company stock worth $17,691,621 over the last 90 days. Company insiders own 0.70% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on ISRG. Stifel Nicolaus lifted their price objective on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a "buy" rating in a report on Thursday, December 5th. Erste Group Bank cut shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a report on Monday, March 17th. JPMorgan Chase & Co. raised their price target on Intuitive Surgical from $575.00 to $675.00 and gave the company an "overweight" rating in a research note on Friday, January 24th. Citigroup boosted their target price on Intuitive Surgical from $640.00 to $711.00 and gave the stock a "buy" rating in a research note on Friday, January 24th. Finally, Barclays increased their price target on shares of Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have assigned a buy rating to the company's stock. According to data from MarketBeat, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and a consensus price target of $611.86.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.